Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
Conditions: Adult Congenital Heart Disease; Heart Failure Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Sponsors: Anita Saraf; The Pittsburgh Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Empagliflozin | Heart | Heart Disease | Heart Failure | Jardiance | Research | Sodium